Litcius/Paper detail

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

Dilara Akbulut, Karissa Whiting, Min-Yuen Teo, Jacob E. Tallman, Gamze Gokturk Ozcan, Merve Başar, Liwei Jia, Rayan Rammal, Jie‐Fu Chen, Judy Sarungbam, Ying‐Bei Chen, Anuradha Gopalan, Samson W. Fine, Satish K. Tickoo, Rohit Mehra, Marina K. Baine, Bernard H. Bochner, Eugene J. Pietzak, Dean F. Bajorin, Jonathan E. Rosenberg, Gopa Iyer, David B. Solit, Victor E. Reuter, Natasha Rekhtman, Irina Ostrovnaya, Hikmat Al‐Ahmadie

2024Modern Pathology17 citationsDOIOpen Access PDF

Topics & Concepts

HematopathologyPathologyNeuroendocrine carcinomaCarcinomaImmunohistochemistryDifferential diagnosisSynaptophysinBiologyMedicineGeneCytogeneticsChromosomeBiochemistryLung Cancer Research StudiesNeuroendocrine Tumor Research AdvancesPeptidase Inhibition and Analysis
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications | Litcius